Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal keratinocyte cell membrane integrity disruption" refers to pathological loss of the structural barrier formed by keratinocyte plasma membranes in the epidermis. This loss of integrity can be induced by a variety of mechanisms including lytic cell death (such as necroptosis, calcium-influx-dependent lysis via TRPV3, or excessive apoptosis), alterations of membrane lipid domains (especially cholesterol-dependent lipid rafts), and external injuries such as solvent exposure. Disruption leads to impaired barrier function, initiating inflammation, increased permeability to pathogens and environmental irritants, and triggering compensatory keratinocyte proliferation and differentiation. No single molecule or receptor defines this entity; rather, it encompasses a constellation of processes and regulatory pathways central to skin pathology and injury responses [1][2][3][4][5][6].
TRPV3-mediated calcium influx leading to lytic cell death; Cholesterol depletion disrupting lipid rafts and signaling; Loss of apoptosis inhibition (e.g., via cFLIP, IAP inhibition) causing excessive keratinocyte death
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal keratinocyte cell membrane integrity disruption.